Pneumocystis carinii Pneumonia in Patients Without AIDS, 1980 Through 1993An Analysis of 78 Cases
Sandra M. Arend, MD;
Frank P. Kroon, MD;
Jan W. van't Wout, MD, PhD
Arch Intern Med. 1995;155(22):2436-2441.
Abstract
| |
Background
Pneumocystis carinii pneumonia (PCP) occurs in immunocompromised patients without the acquired immunodeficiency syndrome (AIDS). There has been an increasing yearly number of cases of PCP in our patients without AIDS.
Objective
To determine the nature of the underlying disorder and previous immunosuppressive treatment in patients with PCP without AIDS.
Method
A study of the charts of 78 such patients admitted to our hospital from 1980 through 1993.
Results
The number of PCP cases per year increased during the period studied. All patients had an underlying disorder, either hematologic malignancy (49%), solid organ tumor (4%), vasculitis or other immunologic disorder (22%), or they had undergone renal transplantation (17%) or bone marrow transplantation (9%). Previous immunosuppressive medication consisted of prednisone or other corticosteroids in 72 (92%) of 78 patients, cytotoxic drugs in 55 (71%) of 78 patients, both in 50 (64%) of 78 patients, and none in one patient. Quantification of previous corticosteroid treatment showed a large variability among patients. The overall mortality rate for patients was 35% (27/78). Mortality was significantly higher in patients with a concomitant pulmonary infection (P=.01), an underlying disorder other than that which resulted in renal transplantation (P=.03), mechanical ventilation (P<.001), previous chemotherapy (P=.04), as well as previous cyclophosphamide treatment (P=.01). A trend toward a higher mortality in patients with previous corticosteroid use was detected (P=.06).
Conclusion
Pneumocystis carinii pneumonia may complicate a variety of immunocompromised states, with considerable mortality. Pneumocystis carinii pneumonia occurred at all levels of immunosuppression; no threshold level could be defined.
(Arch Intern Med. 1995;155:2436-2441)
Author Affiliations
From the Department of Infectious Diseases, University Hospital, Leiden, the Netherlands.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Polymerase Chain Reaction for Diagnosing Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients With Pulmonary Infiltrates
Azoulay et al.
Chest 2009;135:655-661.
ABSTRACT
| FULL TEXT
Clinical Picture of Pneumocystis jiroveci Pneumonia in Cancer Patients
Bollee et al.
Chest 2007;132:1305-1310.
ABSTRACT
| FULL TEXT
Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study
Hui and Kwok
J Med Microbiol 2006;55:85-88.
ABSTRACT
| FULL TEXT
Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
Rodriguez and Fishman
Clin. Microbiol. Rev. 2004;17:770-782.
ABSTRACT
| FULL TEXT
Pneumocystis Carinii Pneumonia in Adult Non-HIV Disorders
Gilmartin and Koziel
J Intensive Care Med 2002;17:283-301.
ABSTRACT
Pneumocystis carinii pneumonia in heart transplant recipients
Cardenal et al.
Eur. J. Cardiothorac. Surg. 2001;20:799-802.
ABSTRACT
| FULL TEXT
Management and Outcome Patterns for Adult Pneumocystis carinii Pneumonia, 1985 to 1995 : Comparison of HIV-Associated Cases to Other Immunocompromised States
Mansharamani et al.
Chest 2000;118:704-711.
ABSTRACT
| FULL TEXT
Peripheral Blood CD4 + T-Lymphocyte Counts During Pneumocystis carinii Pneumonia in Immunocompromised Patients Without HIV Infection
Mansharamani et al.
Chest 2000;118:712-720.
ABSTRACT
| FULL TEXT
Corticosteroids in Acute Respiratory Failure
JANTZ and SAHN
Am. J. Respir. Crit. Care Med. 1999;160:1079-1100.
FULL TEXT
Fulminant Pneumocystis carinii Pneumonia in 4 Patients With Dermatomyositis
Bachelez et al.
Arch Intern Med 1997;157:1501-1503.
ABSTRACT
|
